Answer
Disopyramide phosphate showed no fetal harm in animal teratogenicity tests, but human pregnancy safety is unestablished, uterine contractions have been reported, and use is appropriate only if benefits clearly outweigh possible risks to mother and fetus.
Sources for this answer
- Disopyramide Neon 250 mg Prolonged-Release TabletsNeon Healthcare Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked